Dr. Peter Keyes Sculco, MD

Dr. Sculco practices at Hospital for Special Surgery in New York, New York, part of Hospital for Special Surgery.

Dr. Sculco's NPI, 1699001909, was assigned on October 20, 2009. Dr. Sculco graduated from Vagelos College of Physicians and Surgeons in 2009. Dr. Sculco holds New York license 261863.

Dr. Sculco's primary practice is Hospital for Special Surgery, at 535 East 70th Street, New York, NY 10021 in New York County. The practice phone is (212) 606-1000.

Dr. Sculco's primary practice is Hospital for Special Surgery in New York, New York, part of Hospital for Special Surgery. Dr. Sculco is also affiliated with Kessler Institute for Rehabilitation - West Orange. The medical group on file is Hospital for Special Surgery (HSS). Dmand AI also links Dr. Sculco to 5 more home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sculco practices, 7 sites in all. Vendor and product names are available with a free account.

Adult reconstructive orthopaedic surgery is Dr. Sculco's primary specialty in the NPI Registry, under taxonomy code 207XS0114X. Dr. Sculco is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Sculco's licenses on file in 2 states: New York and Minnesota.

Dmand AI lists arthritis, bursitis, fluid in a joint, hip replacement, joint pain, knee replacement, lower back pain and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Sculco treats.

CMS data shows 2,388 Medicare services from Dr. Sculco across 9 procedure codes in 2024, for 536 Medicare patients. Medicare paid $321,345 for them.

CMS counts 536 Medicare patients who saw Dr. Sculco in 2024. The largest group is 65 to 74, with 243 patients. 75% of them have arthritis, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sculco's median patient age at 72, with 62% women.

In 2024, Dr. Sculco wrote 62 Medicare Part D claims for 32 patients. 100% of them were for generic drugs. CMS names the drug for 34 of them, across 2 drugs with 11 or more claims each, at $742 in total drug cost. In 2023, CMS named 40 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sculco for performance year 2024, reported as part of a group. Dr. Sculco accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sculco as offering telehealth. CMS counts 181 procedures of knee replacement by Dr. Sculco, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 374 papers to Dr. Sculco, published from 2008 to 2025. 2021 was the busiest year, with 54. The most frequent topics are Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip and Reoperation. Dr. Sculco has published most often in J Arthroplasty. Dr. Sculco's most frequent co-authors are David Mayman, MD, Brian P. Chalmers, MD and Thomas Peter Sculco, MD.

CMS Open Payments shows 676 general payments to Dr. Sculco from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Zimmer Biomet Holdings, Inc. paid the most, $1,069,610.

Dr. Sculco graduated from Vagelos College of Physicians and Surgeons in 2009.

Dr. Sculco is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.